News
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, months before they were abruptly fired by U.S. Health Secretary Robert F ...
14d
Zacks Investment Research on MSNMRNA Stock Jumps on CDC's Revised RSV Vaccine RecommendationsShares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
2d
Verywell Health on MSNNot Enough Adults Are Getting the RSV Vaccine. Here's Why That Matters“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna shares were up 5.9% on Wednesday, while Pfizer was up 1%. GSK’s American ...
15d
MedPage Today on MSNCDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV ShotWith the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...
The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.. The ...
MADISON, Wis. -- The Centers for Disease Control and Prevention announced Wednesday it has updated its recommendations for the use of RSV vaccines in people ages 60 and older. The CDC now ...
The endorsement from CDC Director Dr. Rochelle Walensky follows recommendations from the agency’s independent vaccine advisory committee and approvals from the US Food and Drug Administration ...
In today's health headlines, the CDC changes its RSV vaccine recommendations, fruits and vegetables may have the power to reduce the risk for some serious diseases and emergency medicine doctors ...
The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed the use of respiratory syncytial virus (RSV) vaccines for adults aged 50 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results